Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria
Open Access
- 10 October 2008
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1), 207
- https://doi.org/10.1186/1475-2875-7-207
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- C5 deficiency and C5a or C5aR blockade protects against cerebral malariaThe Journal of Experimental Medicine, 2008
- The Classical and Regulatory Functions of C1q in Immunity and AutoimmunityCellular & Molecular Immunology, 2008
- Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of diseaseThe Journal of Experimental Medicine, 2008
- Expression Microarray Analysis Implicates Apoptosis and Interferon-Responsive Mechanisms in Susceptibility to Experimental Cerebral MalariaThe American Journal of Pathology, 2007
- Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase‐3 and ultrastructural alterations in different disease stagesNeuropathology and Applied Neurobiology, 2007
- Iron Ions and Haeme Modulate the Binding Properties of Complement Subcomponent C1q and of ImmunoglobulinsScandinavian Journal of Immunology, 2007
- Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationThe FASEB Journal, 2006
- Gene‐Expression Profiling Discriminates between Cerebral Malaria (CM)–Susceptible Mice and CM‐Resistant MiceThe Journal of Infectious Diseases, 2006
- Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral MalariaThe Journal of Experimental Medicine, 2002
- Expression of complement in the brain: role in health and diseaseImmunology Today, 1996